No financial scores yet. The Financial Health Scanner runs nightly and will score this company on its next cycle.
Recent Signals
19 foundBioNTech SE
news_score: null · bearish_pct: null · bullish_pct: null
5/5/2026
55%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
12/2/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
8/6/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
8/6/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
8/6/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
8/6/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
8/6/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
8/6/2025
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
6/2/2023
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
6/2/2023
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
6/2/2023
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
6/2/2023
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
6/2/2023
45%
BioNTech SE
role: Executive · event_type: appointment · interpretation: C-suite appointment — monitor for subsequent strategic announcements
6/2/2023
45%
Watch Reason
S&P 500 / major index component — seeded via EDGAR